Published in Medical Letter on the CDC and FDA, January 9th, 2005
Spaulding, a teaching affiliate of Harvard Medical School, is a premier rehabilitation facility in the United States and the second rehabilitation center to participate in the study.
Cyberkinetics received regulatory clearance from the U.S. Food and Drug Administration (FDA) in March of 2004 to study the BrainGate Neural Interface System under an Investigational Device Exemption (IDE).
In the first several weeks of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.